Summary
The global Chronic Idiopathic Constipation (CIC) Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Lubiprostone
Linaclotide
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others
Company Coverage (Sales data, Main Products & Services etc.):
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Chronic Idiopathic Constipation (CIC) Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Lubiprostone
Linaclotide
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others
Company Coverage (Sales data, Main Products & Services etc.):
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Chronic Idiopathic Constipation (CIC) Drugs Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Chronic Idiopathic Constipation (CIC) Drugs Market by Type
2.1 By Type
2.1.1 Lubiprostone
2.1.2 Linaclotide
2.1.3 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Hospitals & Clinics
3.1.2 Ambulatory Surgical Centres
3.1.3 Long Term Care Centres
3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Actavis (Company Profile, Sales Data etc.)
5.2 Chugai Pharmaceutical (Company Profile, Sales Data etc.)
5.3 Ferring International Center (Company Profile, Sales Data etc.)
5.4 Synergy Pharmaceuticals (Company Profile, Sales Data etc.)
5.5 Pfizer (Company Profile, Sales Data etc.)
5.6 GlaxoSmithKline (Company Profile, Sales Data etc.)
5.7 Roche Holding (Company Profile, Sales Data etc.)
5.8 Sanofi (Company Profile, Sales Data etc.)
5.9 Bayer (Company Profile, Sales Data etc.)
5.10 Salix Pharmaceuticals (Company Profile, Sales Data etc.)
5.11 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
5.12 Ironwood Pharmaceuticals (Company Profile, Sales Data etc.)
5.13 Progenics Pharmaceuticals (Company Profile, Sales Data etc.)
6 Conclusion
1 Industry Overview
1.1 Chronic Idiopathic Constipation (CIC) Drugs Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Chronic Idiopathic Constipation (CIC) Drugs Market by Type
2.1 By Type
2.1.1 Lubiprostone
2.1.2 Linaclotide
2.1.3 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Hospitals & Clinics
3.1.2 Ambulatory Surgical Centres
3.1.3 Long Term Care Centres
3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 Actavis (Company Profile, Sales Data etc.)
5.2 Chugai Pharmaceutical (Company Profile, Sales Data etc.)
5.3 Ferring International Center (Company Profile, Sales Data etc.)
5.4 Synergy Pharmaceuticals (Company Profile, Sales Data etc.)
5.5 Pfizer (Company Profile, Sales Data etc.)
5.6 GlaxoSmithKline (Company Profile, Sales Data etc.)
5.7 Roche Holding (Company Profile, Sales Data etc.)
5.8 Sanofi (Company Profile, Sales Data etc.)
5.9 Bayer (Company Profile, Sales Data etc.)
5.10 Salix Pharmaceuticals (Company Profile, Sales Data etc.)
5.11 Sucampo Pharmaceuticals (Company Profile, Sales Data etc.)
5.12 Ironwood Pharmaceuticals (Company Profile, Sales Data etc.)
5.13 Progenics Pharmaceuticals (Company Profile, Sales Data etc.)
6 Conclusion
